| Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. WH Lee, RA Morton, JI Epstein, JD Brooks, PA Campbell, GS Bova, ... Proceedings of the National Academy of Sciences 91 (24), 11733-11737, 1994 | 1089 | 1994 |
| Interleukin-6: a candidate mediator of human prostate cancer morbidity DA Twillie, MA Eisenberger, MA Carducci, WS Hseih, WY Kim, ... Urology 45 (3), 542-549, 1995 | 363 | 1995 |
| The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors J Ying, G Srivastava, WS Hsieh, Z Gao, P Murray, SK Liao, R Ambinder, ... Clinical cancer research 11 (18), 6442-6449, 2005 | 254 | 2005 |
| The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor … TJ Seng, JSW Low, H Li, Y Cui, HK Goh, MLY Wong, G Srivastava, ... Oncogene 26 (6), 934-944, 2007 | 170 | 2007 |
| Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial JA Kanakry, H Li, LL Gellert, MV Lemas, W Hsieh, F Hong, KL Tan, ... Blood, The Journal of the American Society of Hematology 121 (18), 3547-3553, 2013 | 159 | 2013 |
| A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable … HY Lim, J Heo, HJ Choi, CY Lin, JH Yoon, C Hsu, KM Rau, RTP Poon, ... Clinical Cancer Research 20 (23), 5976-5985, 2014 | 113 | 2014 |
| Consensus recommendations for management of head and neck cancer in Asian countries: a review of international guidelines A D’cruz, T Lin, AK Anand, D Atmakusuma, MJ Calaguas, I Chitapanarux, ... Oral oncology 49 (9), 872-877, 2013 | 100 | 2013 |
| Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression R Soo, T Putti, Q Tao, BC Goh, KH Lee, L Kwok-Seng, L Tan, WS Hsieh Archives of Otolaryngology–Head & Neck Surgery 131 (2), 147-152, 2005 | 99 | 2005 |
| Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancer WS Hsieh, R Soo, BK Peh, T Loh, D Dong, D Soh, LS Wong, S Green, ... Clinical Cancer Research 15 (4), 1435-1442, 2009 | 93 | 2009 |
| A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors JSW Low, Q Tao, KM Ng, HK Goh, XS Shu, WL Woo, RF Ambinder, ... Oncogene 30 (16), 1923-1935, 2011 | 62 | 2011 |
| Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma SC Lee, SG Lim, R Soo, WS Hsieh, JY Guo, T Putti, Q Tao, R Soong, ... Pharmacogenetics and genomics 16 (1), 73-74, 2006 | 59 | 2006 |
| The biology of Epstein–Barr virus in post‐transplant lymphoproliferative disease WS Hsieh, MV Lemas, RF Ambinder Transplant infectious disease 1 (3), 204-212, 1999 | 58 | 1999 |
| Familial nasopharyngeal carcinoma in a cohort of 200 patients KS Loh, BC Goh, J Lu, WS Hsieh, L Tan Archives of Otolaryngology–Head & Neck Surgery 132 (1), 82-85, 2006 | 52 | 2006 |
| Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression RA Soo, J Wu, A Aggarwal, Q Tao, W Hsieh, T Putti, KB Tan, WL Soon, ... Annals of oncology 17 (11), 1625-1630, 2006 | 44 | 2006 |
| Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma SH Tan, H Ida, BC Goh, W Hsieh, M Loh, Y Ito Anticancer research 26 (6B), 4287-4292, 2006 | 34 | 2006 |
| Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma ASC Wong, RA Soo, JJ Lu, KS Loh, KS Tan, WS Hsieh, TP Shakespeare, ... Annals of Oncology 17 (7), 1152-1157, 2006 | 34 | 2006 |
| Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models NL Syn, PL Lim, LR Kong, L Wang, ALA Wong, CM Lim, TKS Loh, ... Signal Transduction and Targeted Therapy 3 (1), 9, 2018 | 31 | 2018 |
| Systemic therapy of prostate cancer. New concepts from prostate cancer tumor biology WS Hsieh, JW Simons Cancer treatment reviews 19 (3), 229-260, 1993 | 24 | 1993 |
| A phase II trial of MEK inhibitor BAY 86-9766 in combination with sorafenib as first-line systemic treatment for patients with unresectable hepatocellular carcinoma (HCC) HK Ho Yeong Lim, Chia-Jui Yen, Won-Young Tak, Jeong J Clin Oncol (Meeting Abstracts) 30 (suppl), abstr 4103, 2012 | 19* | 2012 |
| Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer LK Goh, N Liem, A Vijayaraghavan, G Chen, PL Lim, KJ Tay, M Chang, ... PLoS One 9 (3), e91666, 2014 | 17 | 2014 |
